CoQ10 and AES pretreatment prevented LPS-induced ALI via reducing the activation of TLR4/MyD88 signaling to downregulate p38 MAPK and ERK1/2 and then inhibit the NLRP3 inflammasome to protect sepsis-induced ALI. The gene discussed is NLRP3; the disease is Sepsis.